BRIEF-Adavaxis completes first two dose-escalation cohorts, launch third dose-escalation cohort in their keynote-046 clinical trial
April 05, 2016 at 09:15 AM EDT
* Says completed first two dose-escalation cohorts and launched third dose-escalation cohort in their keynote-046 clinical trial Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)